Is your child currently experiencing ulcerative colitis flare-ups? Local CD study is testing a potential new medication to see if it may reduce fatigue, perianal fistula, abdominal pain, malnutrition, and/or joint pain associated with ulcerative colitis.
If you’re concerned about how ulcerative colitis affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local trial is testing a potential new medication to see if it may reduce diarrhea with blood, unexplained weight loss, constant need to poop, malnutrition, and/or anemia associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing UC flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce fever, inflammation of the bowel or intestine, diarrhea, malnutrition, and/or eye pain associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people 2–17 years of age to join a Crohn’s disease (CD) clinical research to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or Inflammatory bowel disease (including associated symptoms such as abdominal pain and cramps, growth failure, bloody stool, malnutrition and/or liver disease), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

We are looking for children aged 2 to 17 years to join a CD trial to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or Crohn’s disease (CD) (including associated symptoms such as abdominal cramping, reduced appetite, diarrhea, frequent fevers and/or anemia), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

We are looking for children aged 2 to 17 years to join a CD clinical research to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or UC (including associated symptoms such as abdominal cramping, mouth sores, diarrhea, chronic fatigue and/or canker sores), consider one of our clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your children aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

We are looking for 2 to 17 years old to join a trial to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or ulcerative colitis (UC) (including associated symptoms such as stomach pain, joint pain, rectal pain, weight loss and/or canker sores), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

We are looking for children to join a Crohn’s disease clinical research to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or IBD (including associated symptoms such as diarrhea with pus, fatigue, bloody stool, malnutrition and/or anemia), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

We are looking for children and teens 2–17 years of age to join a UC clinical research study to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or ulcerative colitis (UC) (including associated symptoms such as diarrhea, failure to thrive, bloody stool, malnutrition and/or canker sores), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce cramps, unexplained weight loss, constant need to poop, chronic fatigue, and/or liver disease associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.